Dominique Grau Sells 9,990 Shares of Agilent Technologies, Inc. (NYSE:A) Stock

Agilent Technologies, Inc. (NYSE:A) SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the sale, the senior vice president now owns 40,011 shares of the company’s stock, valued at $5,801,595. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Agilent Technologies Trading Up 0.9 %

A traded up $1.32 on Friday, hitting $148.06. The company had a trading volume of 2,213,007 shares, compared to its average volume of 1,724,966. The business’s fifty day simple moving average is $138.58 and its 200 day simple moving average is $139.11. The company has a quick ratio of 1.37, a current ratio of 1.78 and a debt-to-equity ratio of 0.36. Agilent Technologies, Inc. has a 12-month low of $96.80 and a 12-month high of $155.35. The company has a market cap of $42.54 billion, a PE ratio of 34.69, a PEG ratio of 6.48 and a beta of 1.05.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.06. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The firm had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.56 billion. During the same quarter in the previous year, the business earned $1.43 EPS. The company’s quarterly revenue was down 5.6% on a year-over-year basis. Equities research analysts expect that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st will be issued a $0.236 dividend. The ex-dividend date is Tuesday, October 1st. This represents a $0.94 annualized dividend and a dividend yield of 0.64%. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.22%.

Analyst Ratings Changes

A number of equities research analysts have weighed in on A shares. Stifel Nicolaus reiterated a “buy” rating and set a $151.00 target price on shares of Agilent Technologies in a research note on Monday, August 26th. UBS Group upped their price objective on Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. Wells Fargo & Company started coverage on Agilent Technologies in a research report on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 target price on the stock. JPMorgan Chase & Co. reduced their price target on shares of Agilent Technologies from $165.00 to $155.00 and set an “overweight” rating for the company in a research report on Thursday, May 30th. Finally, Wolfe Research cut shares of Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research note on Thursday, June 27th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $141.60.

Hedge Funds Weigh In On Agilent Technologies

Several hedge funds have recently added to or reduced their stakes in A. Crewe Advisors LLC grew its stake in Agilent Technologies by 114.8% in the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after purchasing an additional 101 shares in the last quarter. Livelsberger Financial Advisory purchased a new position in Agilent Technologies during the fourth quarter valued at approximately $26,000. Ridgewood Investments LLC bought a new position in Agilent Technologies in the second quarter worth approximately $29,000. Rise Advisors LLC lifted its holdings in Agilent Technologies by 527.8% during the first quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock worth $33,000 after buying an additional 190 shares during the period. Finally, YHB Investment Advisors Inc. bought a new stake in Agilent Technologies during the 1st quarter valued at $34,000.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.